Skip to main content
Sinphar Pharmaceutical Co., Ltd. logo

Sinphar Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Filings indexed 1,597 across all filing types
Latest filing 2026-02-10 Regulatory Filings
Country TW Taiwan
Listing TW 1734

About Sinphar Pharmaceutical Co., Ltd.

https://www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
115年1月背書保證與資金貸與
Regulatory Filings
2026-02-10 Chinese
115年1月營業收入
Regulatory Filings
2026-02-10 Chinese
115年01月內部人持股異動(事後)
Regulatory Filings
2026-02-05 Chinese
115年01月董事會成員及持股
Regulatory Filings
2026-02-05 Chinese
功能性委員會成員
Regulatory Filings
2026-01-30 Chinese
114年12月營業收入
Regulatory Filings
2026-01-12 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.